715316825	715316825	CD	B-NP	O
|	|	NN	I-NP	O
DSCH	DSCH	NN	I-NP	O
|	|	NN	I-NP	O
39368889	39368889	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6121802	6121802	CD	B-NP	O
|	|	CC	I-NP	O
3/30/2006	3/30/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/30/2006	3/30/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/10/2006	6/10/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
EVANGELO	EVANGELO	NNP	B-NP	O
,	,	,	O	O
DEANGELO	DEANGELO	NNP	B-NP	O
J.	J.	NNP	I-NP	O
589-43-94-6	589-43-94-6	CD	I-NP	O
Win	Win	NNP	I-NP	O
Ter	Ter	NNP	I-NP	O
Call	Call	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
6/2/06	6/2/06	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
Attending	Attend	VBG	B-VP	O
evaluation	evaluation	NN	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DURTSCHE	DURTSCHE	NNP	B-NP	O
,	,	,	O	O
JERAMY	JERAMY	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Headache	Headache	NNP	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
NEBULIZER	NEBULIZER	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
NEB	NEB	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Shortness	Shortness	NN	I-NP	O
of	of	IN	B-PP	O
Breath	Breath	NNP	B-NP	O
,	,	,	O	O
Wheezing	Wheezing	NNP	B-NP	O
ALLOPURINOL	ALLOPURINOL	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
NORVASC	NORVASC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

VITAMIN	VITAMIN	NNP	B-NP	O
C	C	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASCORBIC	ASCORBIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
5/19	5/19	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
CALTRATE	CALTRATE	NN	I-NP	O
+	+	SYM	B-VP	O
D	D	NN	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
COLCHICINE	COLCHICINE	NN	I-NP	O
0.6	0.6	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
COLACE	COLACE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
ENOXAPARIN	ENOXAPARIN	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
SC	SC	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
ERGOCALCIFEROL	ERGOCALCIFEROL	NNP	I-NP	O
50	50	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QWEEK	QWEEK	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Tuesday	Tuesday	NNP	B-NP	O
;	;	:	O	O
Continue	Continue	NNP	B-NP	O
until	until	IN	B-SBAR	O
5/14	5/14	CD	B-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	B-protein
FLONASE	FLONASE	NNP	I-NP	I-protein
NASAL	NASAL	NNP	I-NP	I-protein
SPRAY	SPRAY	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FLUTICASONE	FLUTICASONE	NNP	I-NP	I-protein
NASAL	NASAL	NNP	I-NP	I-protein
SPRAY	SPRAY	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
2	2	CD	I-NP	I-protein
SPRAY	SPRAY	NN	I-NP	I-protein
NA	NA	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
FLOVENT	FLOVENT	NN	I-NP	I-protein
HFA	HFA	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FLUTICASONE	FLUTICASONE	NN	I-NP	I-protein
PROPIONATE	PROPIONATE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
220	220	CD	I-NP	I-protein
MCG	MCG	NNP	I-NP	I-protein
INH	INH	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
LASIX	LASIX	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
120	120	CD	I-NP	O
MG	MG	NN	I-NP	O
IV	IV	CD	B-NP	O
BID	BID	NN	I-NP	O
X	X	SYM	B-NP	O
4	4	CD	B-NP	O
doses	dose	NNS	I-NP	O
Starting	Start	VBG	B-VP	O
Today	Today	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
5/19	5/19	CD	I-NP	I-protein
-RRB-	-RRB-	NNPS	I-NP	I-protein
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Give	Give	VB	B-VP	O
lasix	lasix	NN	B-NP	O
120mg	120mg	NN	I-NP	O
BID	BID	NN	I-NP	O
x2	x2	NN	I-NP	O
days	day	NNS	I-NP	O
total	total	VBP	B-VP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
reduce	reduce	VB	B-VP	O
to	to	TO	B-PP	O
120mg	120mg	CD	B-NP	O
QAM	QAM	NN	I-NP	O
+	+	SYM	B-NP	O
80mg	80mg	NN	I-NP	O
QPM	QPM	NNP	I-NP	O
.	.	.	O	O

LASIX	LASIX	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
120	120	CD	I-NP	O
MG	MG	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
;	;	:	O	O
80	80	CD	B-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
PO	PO	NN	I-NP	O
120	120	CD	I-NP	O
MG	MG	NN	I-NP	O
QAM	QAM	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
ON	ON	NNP	I-NP	O
7/25/06	7/25/06	CD	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
10	10	CD	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
do	do	VBP	B-VP	O
strict	strict	JJ	B-NP	O
daily	daily	JJ	I-NP	O
weights	weight	NNS	I-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Petti	Petti	NNP	I-NP	O
with	with	IN	B-PP	O
updates	update	VBZ	B-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
HUMALOG	HUMALOG	NNP	B-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
LISPRO	LISPRO	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
Medium	Medium	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
Call	Call	NNP	I-NP	O
HO	HO	NN	I-NP	O
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
60	60	CD	I-NP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
DO	DO	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
supplemental	supplemental	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
1	1	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
5	5	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
7	7	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
Call	Call	VBP	B-VP	O
HO	HO	NN	B-NP	B-protein
if	if	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
350	350	CD	B-NP	O
Please	Please	NN	I-NP	O
give	give	VBP	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
time	time	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
standing	stand	VBG	B-VP	O
mealtime	mealtime	NN	B-NP	O
insulin	insulin	NN	I-NP	O
HUMALOG	HUMALOG	NN	I-NP	O
MIX	MIX	NN	I-NP	O
75/25	75/25	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
LISPRO	LISPRO	NNP	I-NP	O
MIX	MIX	NNP	I-NP	O
75/25	75/25	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
34	34	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
HUMALOG	HUMALOG	NNP	I-NP	O
MIX	MIX	NNP	I-NP	O
75/25	75/25	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
LISPRO	LISPRO	NNP	I-NP	O
MIX	MIX	NNP	I-NP	O
75/25	75/25	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
14	14	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
Q6PM	Q6PM	NN	I-NP	O
COMBIVENT	COMBIVENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
AND	AND	CC	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
IMDUR	IMDUR	NN	I-NP	O
ER	ER	NN	I-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	B-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
LEVAQUIN	LEVAQUIN	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
500	500	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
Instructions	Instruction	NNPS	I-NP	I-DNA
:	:	:	O	O
patient	patient	NN	B-NP	O
taking	take	VBG	B-VP	O
10	10	CD	B-NP	O
day	day	NN	I-NP	O
total	total	JJ	I-NP	O
course	course	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
started	start	VBN	B-VP	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	O
facility	facility	NN	I-NP	O
on	on	IN	B-PP	O
10	10	CD	B-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	B-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Administer	Administer	NNP	I-NP	I-protein
iron	iron	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/2/06	6/2/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
RISPERIDONE	RISPERIDONE	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	B-ADJP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
already	already	RB	B-ADVP	O
taking	take	VBG	B-VP	O
it	it	PRP	B-NP	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NN	I-NP	O
SODIUM	SODIUM	NN	I-NP	O
175	175	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
MILK	MILK	NNP	I-NP	O
OF	OF	IN	B-PP	O
MAGNESIA	MAGNESIA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MAGNESIUM	MAGNESIUM	NNP	I-NP	O
HYDROXIDE	HYDROXIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MILLILITERS	MILLILITERS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
NADOLOL	NADOLOL	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q24H	Q24H	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

PROTONIX	PROTONIX	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
PANTOPRAZOLE	PANTOPRAZOLE	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
RISPERDAL	RISPERDAL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
RISPERIDONE	RISPERIDONE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
0.25	0.25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
TRAZODONE	TRAZODONE	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Anxiety	Anxiety	NN	I-NP	O
MAXZIDE-25	MAXZIDE-25	NN	I-NP	O
-LRB-	-LRB-	SYM	B-VP	O
TRIAMTERENE	TRIAMTERENE	NN	B-NP	B-protein
37.5	37.5	CD	I-NP	I-protein
MG/HYDROCHLOROTHI	MG/HYDROCHLOROTHI	NNP	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
GROUND	GROUND	NN	B-NP	O
/	/	SYM	B-NP	O
2	2	CD	I-NP	O
gm	gm	NN	I-NP	O
Na	Na	NN	I-NP	O
/	/	SYM	B-VP	O
ADA	ADA	NN	B-NP	O
2000	2000	CD	I-NP	O
cals/day	cals/day	NN	I-NP	O
/	/	SYM	B-NP	O
Low	Low	NN	I-NP	O
saturated	saturate	VBD	B-VP	O
fat	fat	JJ	B-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
activity	activity	NN	B-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
,	,	,	O	O
uses	use	VBZ	B-VP	O
wheelchair	wheelchair	WRB	B-ADVP	O
FOLLOW	FOLLOW	NNP	B-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Please	Please	NNP	B-NP	O
call	call	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Kirby	Kirby	NNP	I-NP	O
Deininger	Deininger	NNP	I-NP	O
for	for	IN	B-PP	O
appointment	appointment	NN	B-NP	B-protein
1-2	1-2	CD	I-NP	I-protein
weeks	week	NNS	I-NP	I-protein
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
CAPTOPRIL	CAPTOPRIL	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
h/o	h/o	NNP	I-NP	O
PNEUMONIA	PNEUMONIA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
'93	'93	CD	I-NP	O
,	,	,	I-NP	O
'95	'95	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
ASTHMA	ASTHMA	NN	I-NP	O
NIDDM	NIDDM	NN	I-NP	O
CAD-MIx2	CAD-MIx2	NN	I-NP	O
,	,	,	O	O
3v	3v	CD	B-NP	O
CABG	CABG	NNP	I-NP	O
'92	'92	POS	B-NP	O
HYPOTHYROIDISM	HYPOTHYROIDISM	NNP	I-NP	O
HYPERTENSION	HYPERTENSION	NNP	I-NP	O
Hypercholesterolemia	Hypercholesterolemia	NNP	I-NP	O
Urinary	Urinary	NNP	I-NP	O
Incontinence	Incontinence	NNP	I-NP	O
LVH	LVH	NNP	I-NP	O
,	,	,	O	O
LAE	LAE	NNP	B-NP	O
Tardive	Tardive	NNP	I-NP	O
Dyskinesia	Dyskinesia	NNP	I-NP	O
Periumbilical	Periumbilical	NNP	I-NP	O
Hernia	Hernia	NNP	I-NP	O
R	R	NNP	I-NP	O
rotator	rotator	NN	I-NP	O
cuff	cuff	NN	I-NP	O
injury	injury	NN	I-NP	O
s/p	s/p	NN	I-NP	O
quadriceps	quadricep	VBZ	B-VP	O
tear	tear	NN	B-NP	B-protein
repair	repair	NN	I-NP	I-protein
s/p	s/p	NN	I-NP	I-protein
ankle	ankle	NN	I-NP	I-protein
fx	fx	NN	I-NP	I-protein
Elevated	Elevated	NNP	I-NP	I-protein
ESR	ESR	NNP	I-NP	I-protein
Anemia	Anemia	NNP	I-NP	I-protein
drop	drop	NN	I-NP	I-protein
foot	foot	NN	I-NP	I-protein
copd	copd	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
chronic	chronic	JJ	I-NP	I-protein
obstructive	obstructive	JJ	I-NP	I-protein
pulmonary	pulmonary	JJ	I-NP	I-protein
disease	disease	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
cri	cri	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
chronic	chronic	JJ	I-NP	I-protein
renal	renal	JJ	I-NP	I-protein
dysfunction	dysfunction	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
RUE	RUE	NN	I-NP	I-protein
DVT	DVT	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
PICC	PICC	NN	B-NP	O
line	line	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
diureses	diurese	VBZ	B-VP	O
BRIEF	BRIEF	NN	B-NP	B-protein
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
cc	cc	NN	B-NP	O
:	:	:	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
78F	78F	NN	B-NP	O
with	with	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
,	,	,	O	O
possible	possible	JJ	B-NP	O
COPD	COPD	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
poor	poor	JJ	I-NP	O
PFTs	PFT	NNS	I-NP	O
in	in	IN	B-PP	O
2004	2004	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
admit	admit	NN	I-NP	O
in	in	IN	B-PP	O
5/1	5/1	CD	B-NP	O
for	for	IN	B-PP	O
incarcerated	incarcerate	VBN	B-NP	O
hernia	hernia	NN	I-NP	O
s/p	s/p	NN	I-NP	O
repair	repair	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
left	left	JJ	B-NP	O
frontal	frontal	JJ	I-NP	O
CVA	CVA	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
carotid	carotid	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
NSTEMI	NSTEMI	NN	B-NP	B-protein
,	,	,	O	O
PICC-associated	PICC-associated	JJ	B-NP	O
RUE	RUE	NN	I-NP	O
DVT	DVT	NN	I-NP	O
,	,	,	O	O
enterococcus	enterococcus	NN	B-NP	O
bacteremia	bacteremia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
gout	gout	NN	B-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

Had	Have	VBD	B-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
from	from	IN	B-PP	O
time	time	NN	B-NP	O
to	to	TO	B-PP	O
time	time	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
AM	AM	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
developed	develop	VBN	I-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
.	.	.	O	O

Staff	Staff	NNP	B-NP	O
at	at	IN	B-PP	O
Cet	Cet	NNP	B-NP	O
E	E	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
rehab	rehab	NN	I-NP	O
facility	facility	NN	I-NP	O
noted	note	VBD	B-VP	O
tachypnea	tachypnea	NN	B-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
so	so	RB	B-ADVP	O
EMS	EMS	NNP	B-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
.	.	.	O	O

O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
was	be	VBD	B-VP	O
88	88	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
166/80	166/80	CD	I-NP	I-DNA
,	,	,	O	O
HR	HR	NN	B-NP	B-protein
78	78	CD	I-NP	I-protein
,	,	,	O	O
RR	RR	NN	B-NP	B-protein
38	38	CD	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
TH	TH	NN	I-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
85	85	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
3L	3L	NN	B-NP	O
nc	nc	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
NRB	NRB	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
eventually	eventually	RB	I-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
CPAP	CPAP	NN	B-NP	B-protein
and	and	CC	O	O
given	give	VBN	B-NP	O
lasix	lasix	NN	I-NP	O
120mg	120mg	NN	I-NP	O
iv	iv	NN	I-NP	O
x1	x1	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
nitro	nitro	NN	B-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
improved	improve	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
canula	canula	NN	I-NP	O
and	and	CC	I-NP	O
NTG	NTG	NN	I-NP	B-protein
drip	drip	NN	I-NP	I-protein
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
CABGx3	CABGx3	NN	B-NP	O
1992	1992	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
OM	OM	NN	B-NP	O
,	,	,	O	O
SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
R	R	NN	B-NP	B-protein
PDA	PDA	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
PCI	PCI	NN	B-NP	O
stent	stent	NN	I-NP	O
of	of	IN	B-PP	O
SVG	SVG	NN	B-NP	B-protein
to	to	TO	B-PP	O
OM	OM	NN	B-NP	O
in	in	IN	B-PP	O
2004	2004	CD	B-NP	O
,	,	,	O	O
NSTEMI	NSTEMI	NN	B-NP	B-protein
5/1	5/1	CD	I-NP	I-protein
,	,	,	O	O
IDDM	IDDM	NN	B-NP	O
,	,	,	O	O
Left	Left	NNP	B-NP	O
frontal	frontal	JJ	I-NP	O
CVA	CVA	NN	I-NP	O
5/1	5/1	CD	I-NP	O
with	with	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
left	left	JJ	I-NP	O
internal	internal	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
CMP	CMP	NN	I-NP	O
EF	EF	NN	I-NP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
repair	repair	NN	I-NP	O
of	of	IN	B-PP	O
incarcerated	incarcerate	VBN	B-NP	O
umbilical	umbilical	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
5/1	5/1	CD	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
CRI	CRI	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
baseline	baseline	NN	I-NP	O
1.4-1	1.4-1	CD	I-NP	O
.7	.7	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
RUE	RUE	NN	B-NP	O
DVT	DVT	NN	I-NP	O
5/1	5/1	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PICC	PICC	NN	I-NP	O
associated	associate	VBN	B-VP	O
,	,	,	O	O
discharged	discharge	VBN	B-VP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
week	week	NN	I-NP	O
total	total	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
lovenox	lovenox	NN	B-NP	O
but	but	CC	O	O
is	be	VBZ	B-VP	O
still	still	RB	I-VP	O
taking	take	VBG	I-VP	O
it	it	PRP	B-NP	O
-RRB-	-RRB-	NN	B-NP	B-protein
,	,	,	O	O
tardive	tardive	NN	B-NP	O
dyskinesia	dyskinesia	NN	I-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
back	back	RB	B-ADVP	O
surgery	surgery	NN	B-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
ACEI	ACEI	NN	B-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
avoid	avoid	VB	B-VP	O
all	all	DT	B-NP	O
narcotics	narcotic	NNS	I-NP	O
and	and	CC	I-NP	O
sedatives	sedative	NNS	I-NP	O
SocHx	SocHx	NN	I-NP	O
:	:	:	O	O
living	living	NN	B-NP	O
at	at	IN	B-PP	O
Rangebed	Rangebed	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
Of	Of	IN	B-PP	O
rehab	rehab	NN	B-NP	O
facility	facility	NN	I-NP	O
,	,	,	O	O
diet	diet	NN	B-NP	O
:	:	:	O	O
ground	ground	NN	B-NP	O
,	,	,	O	O
diabetic	diabetic	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
added	add	VBN	I-NP	O
salt	salt	NN	I-NP	O
at	at	IN	B-PP	O
S	S	NNP	B-NP	O
Lee	Lee	NNP	I-NP	O
`	`	``	O	O
slukes	sluke	VBZ	B-VP	O
Medical	Medical	NNP	B-NP	O
Center	Center	NNP	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
person	person	NN	I-NP	O
transfer	transfer	NN	I-NP	O
,	,	,	O	O
self-feed	self-feed	JJ	B-NP	O
Home	Home	NNP	I-NP	O
meds	med	NNS	I-NP	O
:	:	:	O	O
Lasix	Lasix	NNP	B-NP	O
80mg	80mg	CD	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

see	see	VB	B-VP	O
D/C	D/C	NN	B-NP	O
med	med	JJ	I-NP	O
list	list	NN	I-NP	O
below	below	IN	B-PP	O
-LRB-	-LRB-	NN	B-NP	B-protein
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
taking	take	VBG	I-VP	O
Maxzide-25	Maxzide-25	NN	B-NP	B-protein
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

also	also	RB	B-ADVP	O
taking	take	VBG	B-VP	O
10-day	10-day	JJ	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
levaquin	levaquin	NN	B-NP	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
4/30/06	4/30/06	CD	B-NP	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	O
for	for	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
reasons	reason	NNS	I-NP	O
.	.	.	O	O

Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
SOB	SOB	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
stayed	stay	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
with	with	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
.	.	.	O	O

Admitted	Admit	VBN	B-VP	O
,	,	,	O	O
but	but	CC	O	O
never	never	RB	B-VP	O
went	go	VBD	I-VP	O
upstairs	upstairs	RB	B-ADVP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
observation	observation	NN	I-NP	O
unit	unit	NN	I-NP	O
on	on	IN	B-PP	O
6/2/06	6/2/06	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
AM	AM	NN	I-NP	B-cell_type
.	.	.	O	O

She	She	PRP	B-NP	O
diuresed	diurese	VBD	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
120mg	120mg	CD	B-NP	O
iv	iv	JJ	I-NP	O
lasix	lasix	NN	I-NP	O
x1	x1	NN	I-NP	O
.	.	.	O	O

Evaluated	Evaluate	VBN	B-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Steinhouse	Steinhouse	NNP	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
.	.	.	O	O

Likely	Likely	RB	B-NP	O
gradual	gradual	JJ	I-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
salt	salt	NN	I-NP	O
in	in	IN	B-PP	O
diet	diet	NN	B-NP	O
and	and	CC	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
medications	medication	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
taking	take	VBG	I-VP	O
maxzide-25	maxzide-25	NN	B-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
on	on	IN	B-PP	O
lasix	lasix	CD	B-NP	O
80mg	80mg	CD	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
lasix	lasix	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
now	now	RB	I-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
her	her	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
to	to	TO	B-PP	O
120mg	120mg	CD	B-NP	O
po	po	NN	I-NP	O
bix	bix	NN	I-NP	O
x2	x2	NN	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
take	take	VBP	B-VP	O
120mg	120mg	NN	B-NP	O
po	po	NN	I-NP	O
QAM	QAM	NN	I-NP	O
+	+	SYM	O	O
80mg	80mg	CD	B-NP	O
po	po	NN	I-NP	O
QPM	QPM	NNP	B-NP	O
from	from	IN	B-PP	O
now	now	RB	B-ADVP	O
on	on	RB	I-ADVP	O
.	.	.	O	O

Strict	Strict	JJ	B-NP	O
daily	daily	JJ	I-NP	O
weights	weight	NNS	I-NP	O
and	and	CC	O	O
low	low	JJ	B-NP	O
salt	salt	NN	I-NP	O
<	<	SYM	B-VP	O
2gm	2gm	NN	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
RUE	RUE	NN	I-NP	O
DVT	DVT	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
still	still	RB	I-VP	O
receiving	receive	VBG	I-VP	O
lovenox	lovenox	NN	B-NP	O
injections	injection	NNS	I-NP	O
100	100	CD	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
apparently	apparently	RB	B-VP	O
was	be	VBD	I-VP	O
supposed	suppose	VBN	I-VP	O
to	to	TO	I-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
2	2	CD	I-NP	O
week	week	NN	I-NP	O
total	total	JJ	I-NP	O
course	course	NN	I-NP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
medical	medical	JJ	I-NP	O
records	record	NNS	I-NP	O
available	available	JJ	B-ADJP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Lotthammer	Lotthammer	NNP	I-NP	O
believed	believe	VBD	B-VP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
okay	okay	NN	B-ADJP	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
stop	stop	VB	I-VP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
lovenox	lovenox	NN	B-NP	O
for	for	IN	B-PP	O
approximately	approximately	RB	B-NP	O
4-5	4-5	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CODE	CODE	NN	I-NP	O
:	:	:	O	O
FULL	FULL	NN	B-NP	O
.	.	.	O	O

HCP	HCP	NN	B-NP	O
:	:	:	O	O
daughter	daughter	NN	B-NP	O
Clair	Clair	NNP	I-NP	O
Mims	Mims	NNP	I-NP	O
843-193-5920	843-193-5920	CD	I-NP	O
,	,	,	O	O
cell	cell	NN	B-NP	O
:	:	:	O	O
077-692-1935	077-692-1935	CD	B-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DISPO	DISPO	NN	I-NP	O
:	:	:	O	O
D/C	D/C	NN	B-NP	O
to	to	TO	B-PP	O
Morework	Morework	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
rehab	rehab	NN	I-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

May	May	MD	B-VP	O
need	need	VBP	I-VP	O
long-term	long-term	JJ	B-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
care	care	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
near	near	JJ	I-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Hai	Hai	NNP	I-NP	O
Wisch	Wisch	NNP	I-NP	O
is	be	VBZ	B-VP	O
following	follow	VBG	I-VP	O
her	her	PRP	B-NP	O
closely	closely	RB	B-ADVP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Please	Please	NN	I-NP	O
do	do	VBP	B-VP	O
strict	strict	JJ	B-NP	O
daily	daily	JJ	I-NP	O
weights	weight	NNS	I-NP	O
.	.	.	O	O

Call	Call	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Renato	Renato	NNP	I-NP	O
Kushiner	Kushiner	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
reason	reason	NN	I-NP	O
including	include	VBG	B-PP	O
increases	increase	NNS	B-NP	O
in	in	IN	B-PP	O
weight	weight	NN	B-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
call	call	VB	B-VP	O
him	him	PRP	B-NP	O
for	for	IN	B-PP	O
updates	update	VBZ	B-NP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Low	Low	JJ	I-NP	O
salt	salt	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Maximum	Maximum	JJ	B-NP	O
2	2	CD	I-NP	O
grams	gram	NNS	I-NP	O
of	of	IN	B-PP	O
sodium	sodium	NN	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
-RRB-	-RRB-	:	O	O
We	We	PRP	B-NP	O
restarted	restart	VBD	B-VP	O
your	your	PRP$	B-NP	O
Maxzide-25	Maxzide-25	NN	I-NP	B-protein
daily	daily	RB	B-ADVP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Please	Please	NNP	I-NP	O
take	take	VB	B-VP	O
your	your	PRP$	B-NP	O
lasix	lasix	NN	I-NP	B-protein
120mg	120mg	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
total	total	JJ	B-ADJP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
can	can	MD	B-VP	O
then	then	RB	I-VP	O
take	take	VB	I-VP	O
lasix	lasix	NN	B-NP	O
120mg	120mg	NN	I-NP	O
po	po	VBP	B-VP	O
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	I-NP	O
80mg	80mg	NN	I-NP	O
po	po	VBP	B-VP	O
every	every	DT	B-NP	O
night	night	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
-RRB-	-RRB-	:	O	O
We	We	PRP	B-NP	O
stopped	stop	VBD	B-VP	O
your	your	PRP$	B-NP	O
lovenox	lovenox	NN	I-NP	O
injections	injection	NNS	I-NP	O
because	because	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
finished	finish	VBN	I-VP	O
your	your	PRP$	B-NP	O
2	2	CD	I-NP	O
week	week	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Please	Please	NN	I-NP	O
do	do	VBP	B-VP	O
strict	strict	JJ	B-NP	O
daily	daily	JJ	I-NP	O
weights	weight	NNS	I-NP	O
.	.	.	O	O

Call	Call	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Raleigh	Raleigh	NNP	I-NP	O
Philmon	Philmon	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
reason	reason	NN	I-NP	O
including	include	VBG	B-PP	O
increases	increase	NNS	B-NP	O
in	in	IN	B-PP	O
weight	weight	NN	B-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
call	call	VB	B-VP	O
him	him	PRP	B-NP	O
for	for	IN	B-PP	O
updates	update	VBZ	B-NP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Low	Low	JJ	I-NP	O
salt	salt	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Maximum	Maximum	JJ	B-NP	O
2	2	CD	I-NP	O
grams	gram	NNS	I-NP	O
of	of	IN	B-PP	O
sodium	sodium	NN	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
-RRB-	-RRB-	:	O	O
We	We	PRP	B-NP	O
restarted	restart	VBD	B-VP	O
your	your	PRP$	B-NP	O
Maxzide-25	Maxzide-25	NN	I-NP	B-protein
daily	daily	RB	B-ADVP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Please	Please	NNP	I-NP	O
take	take	VB	B-VP	O
your	your	PRP$	B-NP	O
lasix	lasix	NN	I-NP	B-protein
120mg	120mg	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
total	total	JJ	B-ADJP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
can	can	MD	B-VP	O
then	then	RB	I-VP	O
take	take	VB	I-VP	O
lasix	lasix	NN	B-NP	O
120mg	120mg	NN	I-NP	O
po	po	VBP	B-VP	O
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	I-NP	O
80mg	80mg	NN	I-NP	O
po	po	VBP	B-VP	O
every	every	DT	B-NP	O
night	night	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
-RRB-	-RRB-	:	O	O
We	We	PRP	B-NP	O
stopped	stop	VBD	B-VP	O
your	your	PRP$	B-NP	O
lovenox	lovenox	NN	I-NP	O
injections	injection	NNS	I-NP	O
because	because	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
finished	finish	VBN	I-VP	O
your	your	PRP$	B-NP	O
2	2	CD	I-NP	O
week	week	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Check	Check	NNP	I-NP	O
electrolytes	electrolyte	NNS	I-NP	O
-LRB-	-LRB-	IN	B-PP	O
potassium	potassium	NN	B-NP	O
and	and	CC	I-NP	O
magnesium	magnesium	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Keep	Keep	NN	B-NP	O
potassium	potassium	NN	I-NP	O
above	above	IN	B-PP	O
4.0	4.0	CD	B-NP	O
and	and	CC	O	O
magnesium	magnesium	NN	B-NP	O
at	at	IN	B-PP	O
2.0	2.0	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BEDENBAUGH	BEDENBAUGH	NNP	B-NP	O
,	,	,	O	O
SANTOS	SANTOS	NNP	B-NP	O
L	L	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ZU35	ZU35	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6/2/06	6/2/06	CD	I-NP	O
@	@	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
54	54	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

